The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death.

MLA

Tengryd, Christoffer, et al. “The Proteoglycan Mimecan Is Associated with Carotid Plaque Vulnerability and Increased Risk of Future Cardiovascular Death.” Atherosclerosis, vol. 313, Nov. 2020, pp. 88–95. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2020.09.011.

APA

Tengryd, C., Nielsen, S. H., Cavalera, M., Bengtsson, E., Genovese, F., Karsdal, M., Dunér, P., Orho-Melander, M., Nilsson, J., Edsfeldt, A., & Gonçalves, I. (2020). The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death. Atherosclerosis, 313, 88–95. https://doi.org/10.1016/j.atherosclerosis.2020.09.011

Chicago

Tengryd, Christoffer, Signe Holm Nielsen, Michele Cavalera, Eva Bengtsson, Federica Genovese, Morten Karsdal, Pontus Dunér, et al. 2020. “The Proteoglycan Mimecan Is Associated with Carotid Plaque Vulnerability and Increased Risk of Future Cardiovascular Death.” Atherosclerosis 313 (November): 88–95. doi:10.1016/j.atherosclerosis.2020.09.011.